BBIO logo

BridgeBio Pharma, Inc. (BBIO) Long term debt

Annual long term debt:

$2.21B+$469.46M(+27.05%)
December 31, 2024

Summary

  • As of today (September 13, 2025), BBIO annual long term debt is $2.21 billion, with the most recent change of +$469.46 million (+27.05%) on December 31, 2024.
  • During the last 3 years, BBIO annual long term debt has risen by +$482.69 million (+28.02%).
  • BBIO annual long term debt is now at all-time high.

Performance

BBIO Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIObalance sheet metrics

Quarterly long term debt:

$2.67B+$317.20M(+13.50%)
June 30, 2025

Summary

  • As of today (September 13, 2025), BBIO quarterly long term debt is $2.67 billion, with the most recent change of +$317.20 million (+13.50%) on June 30, 2025.
  • Over the past year, BBIO quarterly long term debt has increased by +$942.88 million (+54.67%).
  • BBIO quarterly long term debt is now at all-time high.

Performance

BBIO Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIObalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

BBIO Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+27.1%+54.7%
3 y3 years+28.0%+56.2%
5 y5 years+2302.4%+460.8%

BBIO Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+28.2%at high+56.2%
5 y5-yearat high+2302.4%at high+460.8%
alltimeall timeat high+3945.7%at high+4793.9%

BBIO Long term debt History

DateAnnualQuarterly
Jun 2025
-
$2.67B(+13.5%)
Mar 2025
-
$2.35B(+6.6%)
Dec 2024
$2.21B(+27.0%)
$2.21B(+27.8%)
Sep 2024
-
$1.73B(+0.0%)
Jun 2024
-
$1.72B(+0.0%)
Mar 2024
-
$1.72B(-0.7%)
Dec 2023
$1.74B(+0.9%)
$1.74B(+0.3%)
Sep 2023
-
$1.73B(+0.1%)
Jun 2023
-
$1.73B(+0.3%)
Mar 2023
-
$1.73B(+0.3%)
Dec 2022
$1.72B(-0.2%)
$1.72B(+0.5%)
Sep 2022
-
$1.71B(+0.2%)
Jun 2022
-
$1.71B(-0.9%)
Mar 2022
-
$1.72B(+0.1%)
DateAnnualQuarterly
Dec 2021
$1.72B(+251.1%)
$1.72B(+23.4%)
Sep 2021
-
$1.40B(+0.1%)
Jun 2021
-
$1.39B(+1.3%)
Mar 2021
-
$1.38B(+180.3%)
Dec 2020
$490.53M(+434.4%)
$490.53M(+2.2%)
Sep 2020
-
$480.13M(+0.9%)
Jun 2020
-
$475.68M(+1.2%)
Mar 2020
-
$470.02M(+412.1%)
Dec 2019
$91.79M(+68.4%)
$91.79M(+22.4%)
Sep 2019
-
$75.02M(-86.5%)
Jun 2019
-
$554.04M(+3.8%)
Mar 2019
-
$533.90M(+879.5%)
Dec 2018
$54.51M(-62.1%)
$54.51M
Dec 2017
$143.87M
-

FAQ

  • What is BridgeBio Pharma, Inc. annual long term debt?
  • What is the all time high annual long term debt for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual long term debt year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly long term debt?
  • What is the all time high quarterly long term debt for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly long term debt year-on-year change?

What is BridgeBio Pharma, Inc. annual long term debt?

The current annual long term debt of BBIO is $2.21B

What is the all time high annual long term debt for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual long term debt is $2.21B

What is BridgeBio Pharma, Inc. annual long term debt year-on-year change?

Over the past year, BBIO annual long term debt has changed by +$469.46M (+27.05%)

What is BridgeBio Pharma, Inc. quarterly long term debt?

The current quarterly long term debt of BBIO is $2.67B

What is the all time high quarterly long term debt for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly long term debt is $2.67B

What is BridgeBio Pharma, Inc. quarterly long term debt year-on-year change?

Over the past year, BBIO quarterly long term debt has changed by +$942.88M (+54.67%)
On this page